Our Mission

NDA’s sole commitment is to make sure that the best possible medicines reach the market without unnecessary delay and ensuring that they remain there for as long as they benefit the patients.

Objective, impartial advice tailored to your needs

NDA Group is the regulatory powerhouse of SSI Strategy. For more than 25 years we’ve leveraged our extensive experience and global network to help you optimize your regulatory strategies, expedite filings, and secure successful approvals in key markets worldwide.

By integrating our regulatory proficiency with SSI Strategy's strategic capabilities in clinical development, medical affairs and commercial planning, we provide biotech companies with a holistic solution that maximizes the value of their assets and ensures timely access to innovative therapies.

We understand that bringing a new therapy to market is a complex and challenging endeavor, and we are committed to providing the expertise, insights, and support needed to help you achieve your company vision.

Whether you are a startup biotech looking to optimize your development strategy, or an established player seeking to expand into new markets, we have the knowledge, network, and experience to help you succeed. Partner with us to unlock the full potential of your innovations and bring life-changing therapies to patients without unnecessary delays.




Owner & Founder: Lars-Helge Strömquist
Head Office: Sweden
Founded: 1997

“I wanted to create a company that reflected my own work ethic and values, a company that makes a difference and that secures that good medicines reach patients.”

Lars-Helge Strömquist

Contact Us

Your drug development needs are unique

Contact us to learn how our experts can support you to meet all regulatory, quality and safety requirements and ensure the best path to approval.

Let's Bring Medicines to the World

  • This field is for validation purposes and should be left unchanged.